🚀 VC round data is live in beta, check it out!

Zentiva Valuation Multiples

Discover revenue and EBITDA valuation multiples for Zentiva and similar public comparables like Onconic Therapeutics, Aarti Pharmalabs, Guizhou Sanli, Alkaloid and more.

Zentiva Overview

About Zentiva

Zentiva AS is engaged in the development, production, and distribution of generic medicines. It operates in more than 25 European markets. The company therapeutic areas inlcude Cardiovascular, Central nervous system, Gastrointestinal and metabolic disorders, Anti-inflammatory and pain, Ophthalmology, Anti-infectives, Urology, Respiratory, Blood disorders, and Oncology.


Founded

1993

HQ

Slovakia

Employees

2.5K

Financials (FY)

Revenue:
Net Income:

EV

$666M

Valuation Multiples

Multiples.vc

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Zentiva Stock Performance

Zentiva has current market cap of $666M, and enterprise value of $666M.

EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$666M$666MXXXXXXXXX

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Zentiva Valuation Multiples

Zentiva Financial Valuation Multiples

As of April 23, 2026, Zentiva has market cap of $666M and EV of $666M.

Equity research analysts estimate Zentiva's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

LTMNTMLast FYFY 2026FY 2027FY 2028
Market cap (current)$666MXXX$666MXXXXXXXXX
EV (current)$666MXXX$666MXXXXXXXXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Zentiva Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Valuation Multiples Across 230+ Verticals

Zentiva Public Comps

See public comps and valuation multiples for other Biopharmaceuticals comps.

EV/RevenueEV/EBITDA
LTM2026E2027ELTM2026E2027E
ZentivaXXXXXXXXXXXXXXXXXX
Onconic TherapeuticsXXXXXXXXXXXXXXXXXX
Aarti PharmalabsXXXXXXXXXXXXXXXXXX
Guizhou SanliXXXXXXXXXXXXXXXXXX
AlkaloidXXXXXXXXXXXXXXXXXX
ArvinasXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXX

Valuation data powered by FactSet, Inc.

Zentiva M&A Activity

Zentiva acquired XXX companies to date.

Last acquisition by Zentiva was on XXXXXXXX, XXXXX. Zentiva acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

See M&A valuation multiples

Latest Acquisitions by Zentiva

Acquired CompanyValuationEV/RevenueEV/EBITDA
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.

Start Free Trial

Zentiva Investment Activity

Zentiva invested in XXX companies to date.

Zentiva made its latest investment on XXXXXXXX, XXXXX. Zentiva invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).

See VC round multiples

Latest Investments by Zentiva

CompanyValuationEV/RevenueEV/EBITDA
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Zentiva

When was Zentiva founded?Zentiva was founded in 1993.
Where is Zentiva headquartered?Zentiva is headquartered in Slovakia.
How many employees does Zentiva have?As of today, Zentiva has over 2K employees.
Is Zentiva publicly listed?Yes, Zentiva is a public company listed on BRA.
What is the stock symbol of Zentiva?Zentiva trades under 1SKF401E ticker.
When did Zentiva go public?Zentiva went public in 1997.
Who are competitors of Zentiva?Zentiva main competitors are Onconic Therapeutics, Aarti Pharmalabs, Guizhou Sanli, Alkaloid.
What is the current market cap of Zentiva?Zentiva's current market cap is $666M.
Is Zentiva profitable?No, Zentiva is not profitable.

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial